#6980 on the rich list of 14,644 insiders
Christopher Hite
EVP & Chairman, Partnering at Royalty Pharma. Based in New York, New York.
$13.6M
in disclosed stock, −$137K (−1.00%) today
Live prices, last trade 2:31 PM ET
- Rank
- 6980th of 14,644
- Companies held
- 1
- Largest holding
- RPRX, 100.0% of total
- Latest SEC filing
- Nov 17, 2026
What the $13.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Royalty Pharma RPRX Class A Ordinary Shares | Through SCH Investment Partners LLC | 177,523 | $67.99 | $12.1M | 88.4% | Form 4, Nov 17, 2026 |
| Royalty Pharma RPRX Class A Ordinary Shares | Directly | 23,200 | $67.99 | $1.6M | 11.6% | Form 4, Nov 17, 2026 |
Share counts are the amounts Christopher Hite reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Sold | RPRX | 100,000 | $68.15 | $6.8M | View |
| Sep 22, 2026 | Sold | RPRX | 96,073 | $58.51 | $5.6M | View |
| Sep 22, 2026 | Sold | RPRX | 3,927 | $58.93 | $231K | View |
| Aug 18, 2026 | Sold | RPRX | 100,000 | $59.97 | $6.0M | View |
| Jun 30, 2026 | Sold | RPRX | 2,554 | $57.10 | $146K | View |
| Jun 30, 2026 | Sold | RPRX | 97,446 | $56.50 | $5.5M | View |
| Jun 30, 2026 | Sold | RPRX | 600 | $57.09 | $34K | View |
| Jun 30, 2026 | Sold | RPRX | 29,400 | $56.44 | $1.7M | View |
| Jun 23, 2026 | Sold | RPRX | 117,592 | $54.47 | $6.4M | View |
| Jun 23, 2026 | Sold | RPRX | 32,408 | $54.11 | $1.8M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6977 | Mindaugas Trumpaitis President Combustibles Cat., Philip Morris International. Stamford, CT | $13.6M |
| 6978 | Patrick Hill PRESIDENT, Jacobs Solutions. Dallas, TX | $13.6M |
| 6979 | Kenneth A. Jacobson Chief Financial Officer, Avnet. Phoenix, AZ | $13.6M |
| 6980 | Christopher Hite EVP & Chairman, Partnering, Royalty Pharma. New York, NY | $13.6M |
| 6981 | Lindy Langston 10% owner, Goosehead Insurance. Westlake, TX | $13.6M |
| 6982 | John R. Simon EVP, GC, Chief E&C Officer, PG&E. Oakland, CA | $13.6M |
| 6983 | Francis J Pelzer EVP, Chief Financial Officer, F5. San Jose, CA | $13.6M |
Other Royalty Pharma insiders
All RPRX insiders- Pablo G. Legorreta$336MCEO, Chairman of the Board. #517 overall
- George W. Lloyd$185MEVP, Investments & CLO. #941 overall
- Terrance P. Coyne$132MEVP & CFO. #1226 overall
- James F. Reddoch$57.5MEVP & Chief Scientific Officer. #2312 overall
- Rory B. Riggs$28.6MDirector. #2677 overall
- Gregory Norden$13.3MDirector. #6526 overall
Questions
How much stock does Christopher Hite own?
Christopher Hite holds $13,646,153 in listed stock based on SEC filings and current prices, mostly Royalty Pharma (RPRX). That ranks 6980th on the Stock Rich List.
Is this Christopher Hite's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Christopher Hite last buy or sell stock?
The most recent open-market trade on file is a sale of 100,000 RPRX shares on Nov 17, 2026 at $68.15.